SOURCE: NeutriSci International

NeutriSci International Inc.

March 29, 2017 08:30 ET

NeutriSci Announces Advanced Talks With Several of Canada's Leading Medical Marijuana Companies

VANCOUVER, BC--(Marketwired - March 29, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, confirms it is in advanced discussions regarding product formulation with several of the top companies in Canada's burgeoning cannabis sector.

NeutriSci has been working directly with several companies in Canada's cannabis sector with a view to using NeutriSci's proprietary formulation and form factor within the industry. This formulation utilizes NeutriSci's melt technology and the pterostilbene molecule in combination with various cannabis and cannabidiol actives. Based on research to-date, the Company believes its formulation will enable manufacturers of edible cannabis products to use less active ingredients and better define dose control properties, while still achieving the same desired effects. These effects are like the mechanism that is achieved within neuenergy®, which increases the overall efficacy of standard caffeine by more than 5x.

NeutriSci President Mr. Glen Rehman stated, "We are excited about the potential synergies and partnerships these talks may produce. We have been working with these parties for several months now and are very encouraged with the progress to date."

On Behalf of the Board of Directors of


Glen Rehman, President

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focussed on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries.

Neuenergy® contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Contact Information